Skip to main content

Brain: Tumours

Question for Department of Health and Social Care

UIN 128883, tabled on 21 February 2018

To ask the Secretary of State for Health and Social Care, what assessment he has made of the link between early diagnosis of brain tumours following MRI scans and cancer survival rates; and what steps his Department is taking to improve the early detection of such tumours.

Answered on

26 February 2018

Cancerous brain tumours are difficult to diagnose and often require immediate treatment. Adults with suspected brain and central nervous system cancers are urgently referred for an MRI scan of the brain for assessment1. For diagnosed patients, the survival statistics2 are:

- 14% of patients survive for ten years or more;

- 19% of patients survive for five years or more; and

- 40% of patients survive for one year or more.

Earlier diagnosis is a key priority for NHS England. We are investing £200 million in transformation funding for earlier diagnosis and better post-treatment care and support for cancer patients.

The National Cancer Programme has established a number of initiatives to support ambitions of improving earlier diagnosis including:

- The Accelerate, Coordinate, Evaluate (ACE) programme tests a new, multi-disciplinary diagnostic centre approach to diagnosing patients. The model is focussed on patients with vague or unclear but concerning symptoms, to ensure they receive a diagnosis as quickly as possible; and

- The Faster Diagnosis Standard aims to ensure that patients that are referred for an investigation with a suspicion of cancer, including brain tumours, are diagnosed or have cancer ruled out within 28 days, and we are continuing to move towards national implementation, with a new measurement system going live in hospitals from 1 April 2018.

The Government is also supportive of HeadSmart, a United Kingdom-wide campaign to reduce diagnosis times of childhood brain tumours. The campaign aims to raise national awareness of the common signs and symptoms of a brain tumour in children and young people by equipping parents, the public and healthcare professionals with the information they need.

Finally, last week the Government announced a package, alongside Cancer Research UK and Brain Tumour Research, to boost research and investment into brain tumours. We will commit £20 million, through the National Institute for Health Research (NIHR), over the next five years – with the aim of doubling this amount once new high-quality research proposals become available. Cancer Research UK has also confirmed £25 million over five years in major research centres and programmes dedicated to brain tumours. This research will make new discoveries that the NIHR can then translate into treatments for patients.

Notes:

1National Institute for Health and Care Excellence – https://www.nice.org.uk/guidance/ng12/chapter/1-recommendations-organised-by-site-of-cancer#brain-and-central-nervous-system-cancers

2Cancer Research UK - http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/brain-other-cns-and-intracranial-tumours#heading-Zero

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.